“Hyperuricaemia / gout risk”的搜索结果，显示 231-240 项，共有 11105 项

1. 肾病和高血压- 临床试验- 妙佑医疗国际

   ... risk to the patients: a failure of the algorithm will have no impact on treatment and errors will be caught and corrected by the QC process. Because the ...

2. 抑郁症（重度抑郁障碍） - 症状与病因- 妙佑医疗国际

   抑郁症是一种心境障碍，会引起持续的忧伤和丧失兴趣，并可能干扰日常生活功能。

3. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

4. 妙佑医疗国际移植中心- 临床试验

   The purpose of the study is to optimize and validate the performance of the Senseera liquid biopsy cfChIP-seq assay for the detection of Acute Cellular ...

5. 神经科- 临床试验- 妙佑医疗国际

   The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in ...

6. 血液科- 临床试验- 妙佑医疗国际

   ... Risk (HR) of developing active multiple myeloma. The aim of this study is to ... risk of secondary non-blood-based (hematologic) cancers. Increasing ...

7. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

8. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

9. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

10. 血液科- 临床试验- 妙佑医疗国际

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...